Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study) (EXERT)
Primary Purpose
Intermittent Claudication, Peripheral Vascular Diseases
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Treadmill Exercise Training
Arm Ergometry Exercise Training
Usual Care
Sponsored by
About this trial
This is an interventional treatment trial for Intermittent Claudication focused on measuring Claudication, Peripheral Arterial Disease, Exercise Rehabilitation, Cardiovascular Function
Eligibility Criteria
Inclusion Criteria:
- Has lifestyle-limiting claudication
- Able to walk on a treadmill at 2 mph
- Able to perform arm ergometry exercise
- Able to complete a 12-week exercise program
Exclusion Criteria:
- Physical activities are limited for reasons other than claudication
- Uncontrolled high blood pressure
- Uncontrolled diabetes
- Unstable coronary heart disease
- Ischemic rest pain or tissue loss
- Recent (in the 3 months before study entry) coronary or peripheral revascularization
Sites / Locations
- University of Minnesota
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Active Comparator
Arm Label
Treadmill Exercise Training
Arm Ergometry Exercise Training
Usual Care Control Group
Arm Description
Participants will take part in a 12-week supervised treadmill exercise training program.
Participants will take part in a 12-week supervised aerobic arm ergometry exercise training program.
Participants will receive usual care for PAD from their doctor.
Outcomes
Primary Outcome Measures
Maximal walking distance
Pain-free walking distance
Secondary Outcome Measures
Limb blood flow
Cardiovascular function
Quality of life
Full Information
NCT ID
NCT00895635
First Posted
May 6, 2009
Last Updated
October 30, 2019
Sponsor
University of Minnesota
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
1. Study Identification
Unique Protocol Identification Number
NCT00895635
Brief Title
Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)
Acronym
EXERT
Official Title
Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
April 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Minnesota
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Peripheral arterial disease (PAD) is a disorder that affects more than 8 million people in the United States. As a result of decreased blood flow to the legs, people with PAD may experience leg pain and difficulty with walking. This study will examine the effectiveness of two exercise programs-a treadmill walking program and an aerobic arm exercise program-at increasing walking distance and decreasing leg pain in people with PAD.
Detailed Description
PAD is a condition that occurs when atherosclerotic plaque builds up in the peripheral arteries and restricts blood flow. People with PAD often experience reduced blood flow to the legs, which may cause painful leg cramping while walking, known as intermittent claudication. Claudication affects over 4 million people in the United States, and many people with this condition can walk only ½ to 2 blocks before leg pain begins to occur. Regular treadmill walking has been shown to be effective at increasing walking distance and reducing claudication in people with PAD. However, walking on a treadmill may prove difficult for some people with PAD and usually causes increased leg pain, both of which may reduce exercise frequency. Aerobic arm exercises do not cause leg pain and may be an effective way for people with PAD to improve overall cardiovascular fitness and increase the amount of exercise they do. The purpose of this study is to compare the effectiveness of a treadmill exercise program and an aerobic arm exercise program at reducing symptoms of claudication and improving walking ability in people with PAD.
This study will enroll people with PAD and claudication. At a baseline study visit, participants will complete a treadmill walking test; a blood collection; and questionnaires to assess walking status, daily activity levels, quality of life, and mood. One week after the baseline visit, participants will attend a study visit for an assessment of forearm and leg muscle blood flow and a hand-bike test that will measure upper body strength using an arm cycle ergometer. The ergometer is a device with bicycle pedals that people move using their arms. Participants will then be randomly assigned to either a treadmill exercise training program, an arm ergometry exercise program, or a control group.
Participants in the treadmill exercise training program will attend a supervised program at one of four study sites and exercise on a treadmill for 1 hour three times a week for 12 weeks. Participants in the arm ergometry exercise program will attend a supervised program at one of four study sites and exercise using an arm cycle ergometer (hand-bike) for 1 hour three times a week for 12 weeks. Participants in both groups will also receive written instructions about exercising on their own. Participants in the control group will continue to receive usual care from their regular doctor for the treatment of PAD and will be provided with written exercise instructions. Once a week for 12 weeks, participants in the control group will attend study visits to discuss any health problems.
All participants will be asked to monitor their daily exercise for 3 separate weeks during the 12-week period by wearing an accelerometer, which will measure and record physical activity. They will also record their exercise habits in a written diary. All participants will attend study visits on 2 separate days at Weeks 6 and 12 for repeat baseline testing.
From Weeks 12 to 24, all participants will be encouraged to continue to exercise on their own at least three times a week for 30 minutes. Every 4 weeks, study researchers will call participants to offer encouragement and answer questions. At Week 23, participants will again wear an accelerometer and keep an exercise diary for 1 week. All participants will attend a final study visit at Week 24 for repeat baseline testing.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intermittent Claudication, Peripheral Vascular Diseases
Keywords
Claudication, Peripheral Arterial Disease, Exercise Rehabilitation, Cardiovascular Function
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
104 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Treadmill Exercise Training
Arm Type
Experimental
Arm Description
Participants will take part in a 12-week supervised treadmill exercise training program.
Arm Title
Arm Ergometry Exercise Training
Arm Type
Experimental
Arm Description
Participants will take part in a 12-week supervised aerobic arm ergometry exercise training program.
Arm Title
Usual Care Control Group
Arm Type
Active Comparator
Arm Description
Participants will receive usual care for PAD from their doctor.
Intervention Type
Behavioral
Intervention Name(s)
Treadmill Exercise Training
Intervention Description
60-minute sessions of supervised treadmill exercise training three times a week for 12 weeks
Intervention Type
Behavioral
Intervention Name(s)
Arm Ergometry Exercise Training
Intervention Description
60-minute sessions of supervised aerobic arm exercise training using an arm ergometer three times a week for 12 weeks
Intervention Type
Behavioral
Intervention Name(s)
Usual Care
Intervention Description
Usual care for PAD
Primary Outcome Measure Information:
Title
Maximal walking distance
Time Frame
Measured at baseline and Weeks 6, 12, and 24
Title
Pain-free walking distance
Time Frame
Measured at baseline and Weeks 6, 12, and 24
Secondary Outcome Measure Information:
Title
Limb blood flow
Time Frame
Measured at baseline and Weeks 6, 12, and 24
Title
Cardiovascular function
Time Frame
Measured at baseline and Weeks 6, 12, and 24
Title
Quality of life
Time Frame
Measured at baseline and Weeks 6, 12, and 24
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Has lifestyle-limiting claudication
Able to walk on a treadmill at 2 mph
Able to perform arm ergometry exercise
Able to complete a 12-week exercise program
Exclusion Criteria:
Physical activities are limited for reasons other than claudication
Uncontrolled high blood pressure
Uncontrolled diabetes
Unstable coronary heart disease
Ischemic rest pain or tissue loss
Recent (in the 3 months before study entry) coronary or peripheral revascularization
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Diane J. Treat-Jacobson, PhD, RN
Organizational Affiliation
University of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55455
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)
We'll reach out to this number within 24 hrs